描述

Overview diagram summarizing how targeting soluble guanylate cyclase with nutraceuticals may contribute to bone mass preservation through nitric oxide signaling.

Figure 5

Diagram

Source Paper

Targeting Sirt1, AMPK, Nrf2, CK2, and Soluble Guanylate Cyclase with Nutraceuticals: A Practical Strategy for Preserving Bone Mass.

International journal of molecular sciences (2022)

PMID: 35563167

DOI: 10.3390/ijms23094776

Cite This Figure

![Figure 5: Overview diagram summarizing how targeting soluble guanylate cyclase with nutraceuticals may contribute to bone mass preservation through nitric oxide signaling.]()

> Source: Mark F McCarty et al. "Targeting Sirt1, AMPK, Nrf2, CK2, and Soluble Guanylate Cyclase with Nutraceutic." *International journal of molecular sciences*, 2022. PMID: [35563167](https://pubmed.ncbi.nlm.nih.gov/35563167/)

<figure>
  <img src="" alt="Overview diagram summarizing how targeting soluble guanylate cyclase with nutraceuticals may contribute to bone mass preservation through nitric oxide signaling." />
  <figcaption>Figure 5. Overview diagram summarizing how targeting soluble guanylate cyclase with nutraceuticals may contribute to bone mass preservation through nitric oxide signaling.<br>  Source: Mark F McCarty et al. "Targeting Sirt1, AMPK, Nrf2, CK2, and Soluble Guanylate Cyclase with Nutraceutic." <em>International journal of molecular sciences</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35563167/">35563167</a></figcaption>
</figure>

描述

Figure 5

Source Paper

Cite This Figure

相关证据